Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06ORU
|
|||
| Former ID |
DIB011567
|
|||
| Drug Name |
Butacaine
|
|||
| Synonyms |
Butacaine sulfate; Butelline; Butyn; 149-15-5; Butacaine sulphate; Butacaine sulfate [USP]; UNII-PAU39W3CVB; EINECS 205-733-1; PAU39W3CVB; p-Aminobenzoyldibutylaminopropanol sulfate; Dibutylaminopropyl p-aminobenzoate sulfate; AI3-02405; 3'-Dibutylaminopropyl 4-aminobenzoate sulfate; 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate (ester), sulfate (2:1) (salt); 3-(p-Aminobenzoxy)-1-di-N-butylaminopropane sulfate; 3-(Dibutylamino)-1-propanol p-aminobenzoate (ester) sulfate (2:1)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H30N2O2
|
|||
| Canonical SMILES |
CCCCN(CCCC)CCCOC(=O)C1=CC=C(C=C1)N
|
|||
| InChI |
1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3
|
|||
| InChIKey |
HQFWVSGBVLEQGA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 149-16-6
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:94820
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium channel unspecific (NaC) | Target Info | Modulator | [1], [2] |
| KEGG Pathway | Dopaminergic synapse | |||
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | WO patent application no. 2008,0857,11, Synergy of sodium channel blockers and calcium channel blockers. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.